Head to Head Survey: Azure Power Global (NYSE:AZRE) & CENTRAIS ELETRI/S (NYSE:EBR)

Share on StockTwits

CENTRAIS ELETRI/S (NYSE:EBR) and Azure Power Global (NYSE:AZRE) are both utilities companies, but which is the superior stock? We will contrast the two businesses based on the strength of their analyst recommendations, earnings, institutional ownership, risk, valuation, dividends and profitability.

Profitability

This table compares CENTRAIS ELETRI/S and Azure Power Global’s net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
CENTRAIS ELETRI/S N/A 25.76% 8.56%
Azure Power Global -2.26% -1.01% -0.22%

Analyst Recommendations

This is a summary of current ratings and recommmendations for CENTRAIS ELETRI/S and Azure Power Global, as reported by MarketBeat.com.

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
CENTRAIS ELETRI/S 1 0 0 0 1.00
Azure Power Global 0 0 5 0 3.00

Azure Power Global has a consensus target price of $20.55, suggesting a potential upside of 60.42%. Given Azure Power Global’s stronger consensus rating and higher probable upside, analysts plainly believe Azure Power Global is more favorable than CENTRAIS ELETRI/S.

Insider & Institutional Ownership

0.7% of CENTRAIS ELETRI/S shares are held by institutional investors. Comparatively, 53.3% of Azure Power Global shares are held by institutional investors. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth.

Valuation & Earnings

This table compares CENTRAIS ELETRI/S and Azure Power Global’s gross revenue, earnings per share (EPS) and valuation.

Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
CENTRAIS ELETRI/S $6.83 billion 1.68 $3.30 billion N/A N/A
Azure Power Global $143.52 million 3.66 $1.13 million $0.13 98.54

CENTRAIS ELETRI/S has higher revenue and earnings than Azure Power Global.

Risk and Volatility

CENTRAIS ELETRI/S has a beta of 0.29, indicating that its share price is 71% less volatile than the S&P 500. Comparatively, Azure Power Global has a beta of 1.31, indicating that its share price is 31% more volatile than the S&P 500.

Summary

Azure Power Global beats CENTRAIS ELETRI/S on 6 of the 11 factors compared between the two stocks.

CENTRAIS ELETRI/S Company Profile

Centrais Elétricas Brasileiras S.A. – Eletrobras, through its subsidiaries, engages in the generation, transmission, and distribution of electricity in Brazil. The company generates electricity through thermal, nuclear, wind, and hydroelectric plants. As of December 31, 2017, it owned and operated 44 hydroelectric plants and held interests in various other plants with a total installed capacity of 42,350 Megawatts (MW); 112 thermal plants, including coal, and oil and gas power generation units with an installed capacity of 2,646 MW; and 2 nuclear power plants with an installed capacity of 1,990 MW. The company also operates 71,684 kilometers of transmission lines and 6 power distributors that serve approximately 4.4 million consumers. Centrais Elétricas Brasileiras S.A. – Eletrobrás was founded in 1962 and is based in Rio de Janeiro, Brazil.

Azure Power Global Company Profile

Azure Power Global Limited, together with its subsidiaries, engages in the development, construction, ownership, operation, maintenance, and management of solar power plants in India. It generates solar energy based on long-term contracts with Indian government energy distribution companies, as well as other non-governmental energy distribution companies and commercial customers. As of March 31, 2018, the company had a portfolio capacity of approximately 1,871 megawatts. Azure Power Global Limited was founded in 2007 and is based in New Delhi, India.

Receive News & Ratings for CENTRAIS ELETRI/S Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CENTRAIS ELETRI/S and related companies with MarketBeat.com's FREE daily email newsletter.



Latest News

QuickLogic  Downgraded by Zacks Investment Research to Sell
QuickLogic Downgraded by Zacks Investment Research to Sell
Regeneron Pharmaceuticals  Upgraded to “Buy” by BidaskClub
Regeneron Pharmaceuticals Upgraded to “Buy” by BidaskClub
Proofpoint  Raised to “Buy” at BidaskClub
Proofpoint Raised to “Buy” at BidaskClub
Omeros  Upgraded at BidaskClub
Omeros Upgraded at BidaskClub
360 Finance  Rating Increased to Buy at ValuEngine
360 Finance Rating Increased to Buy at ValuEngine
Kiniksa Pharmaceuticals  Downgraded by Zacks Investment Research to “Sell”
Kiniksa Pharmaceuticals Downgraded by Zacks Investment Research to “Sell”


 
© 2006-2020 Zolmax.